Medical Communications

Showing 15 posts of 6408 posts found.

texting mobile

Health apps now more popular than ever in the UK

October 16, 2015 Medical Communications apps, digital pharma, health technology, technology

The use of health apps has considerably increased over the past years, according to a new survey that has found …
NHS sign

NICE requests more evidence on Duchenne muscular dystrophy therapy

October 16, 2015 Medical Communications, Sales and Marketing Duchenne Muscular Dystrophy, NICE, PCT Therapeutics, Translarna, ataluren

NICE has chosen not to recommend has PTC Therapeutics’ treatment Translarna for Duchenne muscular dystrophy (DMD), asking for further clarification …

The Prime Medical Group expands senior team in New York City

October 15, 2015 Medical Communications The Prime Medical Group

The Prime Medical Group is pleased to announce several key appointments to its New York office as the company continues …
Valeant logo

Valeant receives court writ over US drug pricing

October 15, 2015 Medical Communications, Sales and Marketing Drug pricing, Isuprel, Nitropress, US, Valeant, subpoena

Valeant Pharmaceuticals has disclosed that it has received two subpoenas in the US, demanding evidence concerning the pricing and distribution …
lars-rebien-soerensen

Novo chief executive ranked ‘world’s best’

October 14, 2015 Medical Communications, Sales and Marketing Harvard Business Review, Lars Rebien Sorensen, Novo Nordisk

Novo Nordisk chief executive Lars Rebien Sørensen has been named the best-performing in the world by the Harvard Business Review. …
erik_j

Lisa Rae Schopf and Erik J. Spek bolster Vedanta Biosciences team

October 14, 2015 Medical Communications, Research and Development

Vedanta Biosciences, a PureTech Health company developing a new class of therapies designed to modulate the human microbiome, has announced …

Merck rebrands as ‘science and technology’ company

October 14, 2015 Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Merck Serono, rebrand, restructure

Merck Group has rebranded to “reflect its transformation into a science and technology company”, and restructured its business to create …
berg_niven_narain

Berg interview: artificial intelligence and big data join the war on disease

October 13, 2015 Medical Communications, Research and Development AI, Berg, Big Data, genomics

Boston-based biopharmaceutical company Berg recently announced it joined an industry collaboration with Genomics England, set up by UK Prime Minister …
guido_rasi

EMA appoints Guido Rasi as executive director

October 9, 2015 Medical Communications, Sales and Marketing EMA, Guido Rasi

The European Medicines Agency’s (EMA’s) Management Board has nominated Professor Guido Rasi as the Executive Director of the Agency. The …
money_pills

Oncology groups and doctors fight for lower-priced cancer treatments

October 9, 2015 Medical Communications, Research and Development, Sales and Marketing

Oncology groups such as the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) are working …
sanofi_olivier_brandicourt

Sanofi looks to increase productivity in France by 25%

October 9, 2015 Manufacturing and Production, Medical Communications Sanofi

Sanofi is looking for a deal with unions in order to boost productivity by 20-25% at French plants over three …
astrazeneca_plaque

AstraZeneca’s Moventig now available through NHS

October 9, 2015 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, moventig

AstraZeneca has announced that Moventig (naloxegol) has been made available for adult patients with opioid-induced constipation (OIC) in England and …
bronchial_thermoplasty

Taking on IFP, COPD and severe asthma: ERS 2015 roundup

October 9, 2015 Medical Communications, Research and Development

Leading pharmaceutical companies, physicians, healthcare professionals, scientists, respiratory experts, and of course the media, including Pharmafocus, gathered in Amsterdam at the …
dr_jerome_b_zeldis

Ovid Therapeutics appoints Dr Jerome B. Zeldis to Its Scientific Advisory Board

October 9, 2015 Medical Communications

Ovid Therapeutics, a privately held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain, has …
diabetes_uk_logo

Novo Nordisk and Diabetes UK extend ‘Clinical Champions’ initiative

October 6, 2015 Medical Communications Novo Nordisk, diabetes

Diabetes UK and Novo Nordisk have announced the appointment of 20 Diabetes UK ‘Clinical Champions’, who will be supported and …
The Gateway to Local Adoption Series

Latest content